B

Baxter International

Global provider of medical care products

Product Specialist

Full-Time
No salary listed
Mid
Guayaquil, Ecuador
In PersonTravel required; role focuses on Cuenca and the Sierra region.
Sales & Account ManagementField Sales

About the job

Requirements
  • Technical or professional training in a health-related area.
  • Experience in positions with similar responsibilities.
  • Previous clinical or patient-care experience.
  • Knowledge of the market and Sierra region, particularly Cuenca and surrounding areas.
  • Proficiency with Microsoft Office.
  • Personal vehicle.
  • Availability to travel.
Responsibilities
  • Implement marketing and commercial development strategies for assigned products, ensuring effective execution in the market.
  • Provide technical and scientific advice to clients, healthcare professionals, and other key audiences.
  • Plan and conduct client visits in accordance with commercial objectives and business strategy.
  • Develop and strengthen scientific relationships with key opinion leaders and relevant medical societies.
  • Train healthcare personnel in the appropriate use of Baxter technologies and products.
  • Identify business opportunities and promote initiatives that contribute to growth of the assigned portfolio.
  • Stay up to date on clinical and scientific information and market trends to offer high-value solutions to clients.
  • Prepare and present management and results reports according to business requirements.

About the company

B

Baxter International

View
Website

Baxter International produces medical products and equipment used in hospitals and blood banks. Its innovations include sterile IV solutions and blood-storage technologies, such as the Transfuso-Vac that extended blood shelf life and a plastic blood storage container. The company differentiates itself through a long history of sterile manufacturing, blood-storage breakthroughs, and strategic acquisitions that expand its product portfolio and scale. Its goal is to provide reliable, safe medical products that support patient care and hospital operations worldwide.

Company Size

10,001+

Company Stage

IPO

Headquarters

Deerfield, Illinois

Founded

1931

Get referred to Baxter International

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Baxter raised 2026 sales guidance after Q2 revenue reached $2.96 billion.
  • John Rogers becomes CFO on October 1, 2026, sharpening execution and balance-sheet repair.
  • Kidney Care divestiture and restructuring support higher margins, free cash flow, and leverage reduction.

What critics are saying

  • August 2026 recalls hit saline, dextrose, and citrate for fiberglass and steel contamination.
  • Baxter disclosed unauthorized third-party app access on August 13, 2026; ShinyHunters leaked 7.1 million records.
  • IV-bag tampering litigation and repeated contamination failures threaten trust, contracts, and plant shutdowns.

What makes Baxter International unique

  • Baxter sells essential sterile IV fluids, pumps, and hospital consumables globally.
  • Its legacy hospital distribution relationships and installed base create sticky replenishment demand.
  • Q2 2026 sales rose 5%, showing resilient core positions across segments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Unlimited Paid Time Off
  • Paid Vacation
  • Paid Parental Leave
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Stock Purchase Plan
  • Commuter Benefits

Growth & Insights and Company News

6 month growth

12%

1 year growth

13%

2 year growth

13%
Gulf Times
Oct 25th, 2026
Qatar among the first to adopt baxter's secure, connected vital signs monitoring technology.

Qatar among the first to adopt baxter's secure, connected vital signs monitoring technology. New patient monitoring solution automates vital signs documentation and protects patient data, supporting Qatar's National Vision 2030 ambitions for an integrated health system Published on October 25, 2026 | 11:57 AM Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of the Welch Allyn Connex 360 Vital Signs Monitor in Qatar, among the first markets to introduce the technology. The launch event in Doha, brought together healthcare leaders, clinicians, and IT specialists from the Ministry of Interior, Hamad Medical Corporation, The View Hospital, Military Medical City Hospital, and Sidra Medicine, who experienced live demonstrations of Connex 360's automated documentation and Early Warning Score capabilities. The launch comes as Qatar continues to advance its healthcare transformation agenda under Qatar National Vision 2030 and the National Health Strategy 2024-2030 "Health for All," which aims to build a health-focused society supported by an integrated health system centered on clinical excellence, sustainability and innovation. Continued investment in digital health infrastructure and interoperable systems has created an environment where connected care technologies can be adopted and scaled effectively. Vital signs are among the most frequently recorded measurements in healthcare settings, yet in many environments they continue to be documented manually. This process can take valuable time away from patient care and may introduce transcription errors where accuracy is critical. As the latest innovation, Connex 360 captures a complete set of vital signs, including blood pressure, temperature, pulse rate, and blood oxygen levels, in less than a minute. Configurable Early Warning Score protocols help care teams identify patients whose condition may be deteriorating, supporting earlier clinical intervention. The monitor automatically records patients' vital signs and transfers them securely to hospital information systems, reducing the need for manual documentation. "Healthcare systems across Qatar continue to embrace innovation that improves the quality and efficiency of care," said Beata Karasinska, general manager, Central Eastern Europe, Middle East, Türkiye and Africa (CEEMEA) at Baxter. "We are proud to introduce Connex 360 in Qatar and to support healthcare providers with a connected monitoring solution that helps clinicians access timely patient information, streamline workflows and spend more time with their patients, with the confidence that patient data is protected. This launch reflects our long-term commitment to the country and to our mission to Save and Sustain Lives." As healthcare systems become increasingly connected, protecting patient information remains a priority. Connex 360 uses end-to-end encryption and certificate-based authentication to help safeguard data as it moves between the bedside and hospital systems. Building on a long history of innovation in patient monitoring through the Welch Allyn portfolio, Baxter continues to invest in connected care technologies that help healthcare providers improve efficiency, enhance patient safety and support better clinical outcomes. Last Edited October 25, 2026 | 12:02 PM

Yahoo Finance
Oct 23rd, 2026
Monster is an S&P 500 stock to buy ($92.66B cap), while Twilio and Baxter may struggle

StockStory has picked one S&P 500 stock to buy and two to sell, saying not every company in the index is a winner. Monster Beverage is the buy. The energy drink maker, with a market cap of $92.66 billion, has a 28.6% operating margin and a 35.4% return on capital. Its shares trade at $47.46, or 37.9x forward earnings. Twilio is a sell. The $38.95 billion communications platform grew revenue 14.7% a year over two years, slower than software peers, and its gross margin is 48.6%. Shares trade at $254.75, or 6.7x forward sales. Baxter is also a sell. The $13.26 billion healthcare products maker saw earnings per share fall 8.5% a year over five years and posts negative returns on capital. Shares trade at $25.45, or 11.9x forward earnings.

HR Katha
Sep 21st, 2026
Selvi Supuriamaniam's role expanded to HR director-India, Stanley Black & Decker.

Selvi Supuriamaniam's role expanded to HR director-India, Stanley Black & Decker. Since 2024, Supuriamaniam has been serving as HR director-Middle East & East West Africa By HRK News Bureau September 21, 2026 2 Mins Read 687 Views Selvi Supuriamaniam, who is the HR director, Middle East & East-West Africa, Stanley Black & Decker, has now taken on the additional role of HR director for India. She has been with the British tools and innovative solutions company since 2024. Supuriamaniam began as a humble HR executive in August of 2007, with Kao Penang Group of Malaysia. Less than five years later, she moved to Coca-Cola Bottlers (Malaysia) as human resource business partner, in May of 2012. Just over a year later, she was elevated to head-organisational development and learning, in September of 2013. Nine months into this role, she was promoted to talent acquisition manager-Malaysia, Singapore and Brunei. After five successful years with Coca-Cola, Selvi Supuriamaniam moved to Baxter International as human resource manager. General Mills roped her in to play senior HR manager (South East Asia) in July of 2018. Over a year into this role, she was promoted to head HR (Middle East and Africa). Over two years later she was elevated once again to lead-Asia Women Leadership Network. This role required her to relocate to Dubai, United Arab Emirates. October of 2021 saw her elevated to head-talent and organisational effectiveness, global emerging markets (GEMS). Among other responsibilities, she designed, developed, and implemented global innovative talent-management programmes and processes to improve depth, quality and engagement of talent across the organisation. After a year's career break, Supuriamaniam took up the role of HR director Middle East and East West Africa in July of 2024. With her responsibilities expanded now, she will handle India as part of the multiple markets she is responsible for. HRKatha wishes Selvi Supuriamaniam all the best!

McDowell News
Sep 4th, 2026
Baxter International issues recall of IV solutions made at McDowell County plant.

Baxter International issues recall of IV solutions made at McDowell County plant. Baxter International has issued two recalls of intravenous products which were manufactured at the plant in the North Cove community of McDowell County. Get the latest local business news delivered FREE to your inbox weekly. Staff Writer

FOX8 WGHP
Sep 4th, 2026
Fiberglass found in IV solution made in North Carolina: FDA.

Fiberglass found in IV solution made in North Carolina: FDA. Posted: Sep 4, 2026 / 08:09 AM EDT Updated: Sep 4, 2026 / 08:09 AM EDT MCDOWELL COUNTY, N.C. (WSPA) - A medical equipment company recalled two lots of IV solution last week after potential fiberglass contamination was identified in products manufactured in western North Carolina. Baxter Healthcare issued a voluntary recall on Aug. 25 for two lots of 0.9% Sodium Chloride Injection. According to the FDA, particulate matter in injectable products can cause blood clotting, which can lead to permanent organ damage or death. The product was manufactured at the company's North Cove facility outside of Marion. The solution was distributed to providers from July 31 through Aug. 3, 2026, in the Carolinas and Georgia, as well as Florida, Illinois, Indiana, Louisiana, Maryland, New Jersey, Nevada, New York, Ohio, Texas, and Virginia. The product is packaged in 500 mL VIAFLEX plastic containers, with 24 units in each case. In a statement shared with 7NEWS, Baxter said it initiated the recall in coordination with the FDA after identifying potential particulate matter in the affected solutions. Top headlines on MyFOX8.com. As of Sept. 1, the company said it had not received any reports of adverse events associated with the recalled lots. Health care providers should discontinue use of and return all affected units according to their facility's recall procedures. Health care providers with questions about the recall can contact the Baxter Healthcare Center for Service at (888) 229-0001 between 7 a.m. and 6 p.m. CDT, Monday through Friday.